Clinical Trial Technology Editorial
-
5 Ways AI Is Changing Clinical Research — And How To Embrace It
5/15/2025
Discover how AI is transforming clinical trials, learn real tools already in use, and get practical guidance for clinical professionals — especially CRAs and site teams — looking to upskill in an AI-enhanced environment.
-
How Recursion Is Industrializing Clinical Trials With AI
5/12/2025
Recursion SVP of Clinical Development and Data Science Sid Jain discusses the company's three-point "ClinTech" strategy, focusing on AI-assisted trial design, trial execution, and evidence generation.
-
The Risk And Reward Of Clinical Investigators Integrating AI
5/1/2025
Husch Blackwell LLP experts discuss relevant regulatory frameworks and the risks and liabilities of clinical investigators using AI.
-
Track Your Trial's Carbon Footprint With This Sustainability Calculator
4/24/2025
Pistoia Alliance Portfolio Lead Thierry Escudier discusses the latest updates to the Clinical Trial Carbon Calculator.
-
The Risks Of AI In Clinical Research From A Trial Management Perspective
4/9/2025
In part two of this series, consultant Donatella Ballerini explores the challenges of integrating AI into eTMF management and how to mitigate them.
-
How AI Models Can Actually Improve eTMF Management
4/8/2025
GCP consultant Donatella Ballerini explores how AI is shaping eTMF management and what this means for the future of clinical research in part one of this series.
-
How AI Redefines The Functional Service Provider Opportunity In Medical Affairs
4/7/2025
Medical affairs can no longer afford to operate within legacy structures. Enter AI-enabled functional service provider (FSP) models that offer operational relief.
-
3 Generative AI Prompts To Strengthen Your SOPs Without Sacrificing Compliance
4/1/2025
Discover three easy and customizable prompts to help support SOP development, refinement, and training — all areas where AI can add immediate value with minimal downside.
-
Multiple Partnerships Help Drive Precision Medicine Trial For Parkinson's
3/31/2025
Neuron23 CMO Sam Jackson, MD, explains the company’s desire to set a new standard in precision medicine for neurology, backed by well-aligned partnerships and fit-for-purpose digital biomarker solutions.
-
De-Risk Cytokine Release Syndrome With Digital Health Tech
3/19/2025
Nearly 80% of patients undergoing CAR T cell therapy experience cytokine release syndrome, and Digital Medicine Society (DiMe) has the advice and resources to enable early detection and prediction.